EQRx Investor Relations Material
Latest events
Q1 2023
EQRx
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from EQRx Inc
Access all reports
EQRx, Inc. is a biotechnology company focused on developing and delivering innovative medicines at more affordable prices. The company aims to address the high cost of drugs by re-engineering the drug discovery and development process, creating therapies for conditions such as cancer and immune-inflammatory diseases. EQRx seeks to offer high-quality treatments that are more accessible to healthcare systems and patients. The company collaborates with global partners to advance its drug pipeline while leveraging advanced technologies to expedite drug development and reduce costs. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
EQRX
Country
🇺🇸 United States